Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) EVP Steve Weinrauch sold 11,916 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $53.00, for a total value of $631,548.00. Following the completion of the transaction, the executive vice president now directly owns 48,978 shares in the company, valued at approximately $2,595,834. This trade represents a 19.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Trupanion Trading Up 1.8 %
TRUP opened at $53.60 on Friday. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The firm has a market capitalization of $2.27 billion, a PE ratio of -167.50 and a beta of 1.69. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. The company’s 50-day moving average is $49.05 and its 200 day moving average is $39.26.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company’s quarterly revenue was up 14.6% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.10) earnings per share. As a group, research analysts predict that Trupanion, Inc. will post -0.23 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Trupanion
Analyst Ratings Changes
TRUP has been the topic of a number of research reports. Bank of America boosted their target price on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research report on Friday, September 20th. Northland Securities upped their price objective on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Stifel Nicolaus upped their price target on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Finally, Piper Sandler increased their price target on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Trupanion has a consensus rating of “Moderate Buy” and an average target price of $44.67.
View Our Latest Report on TRUP
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- What is the Australian Securities Exchange (ASX)
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- How to Read Stock Charts for Beginners
- MarketBeat Week in Review – 11/18 – 11/22
- Technology Stocks Explained: Here’s What to Know About Tech
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.